Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation
Launched by JOHNS HOPKINS UNIVERSITY · May 19, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new treatment for people who have experienced a traumatic brain injury (TBI) at least two years ago. The focus is on using a method called transcranial direct current stimulation (tDCS), which is a safe and non-invasive technique that delivers a gentle electrical current to stimulate the brain. The goal is to see if combining tDCS with cognitive training can help improve thinking skills and decision-making in individuals with TBI. This approach is personalized, meaning that the treatment will be tailored to meet the specific needs of each participant.
To be eligible for this trial, participants must be right-handed, able to speak English, and have been diagnosed with TBI at least two years prior. However, individuals with certain conditions, such as uncorrected vision or hearing problems, or those who have had a stroke or other serious brain issues, cannot participate. The trial is currently not recruiting participants, but once it begins, those who qualify can expect to receive targeted brain stimulation alongside cognitive exercises designed to help improve their everyday functioning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of traumatic brain injury (TBI) at least 2 years prior to participation
- • Right-handed
- • English - speaking
- Exclusion Criteria:
- • Uncorrected visual impairment
- • Uncorrected hearing impairment
- • Stroke or other premorbid neurological disorders affecting the brain
- • Premorbid learning disorders
- MRI Exclusion Criteria:
- • severe claustrophobia
- • Cardiac pacemakers, ferromagnetic implants, cochlear implants
- • pregnant woman
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kyrana Tsapkini, PhD.
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported